|
2025
|
G/S
|
vaccines for human use. |
|
|
G/S
|
Vaccines for human use |
|
|
G/S
|
Vaccines for human use |
|
|
G/S
|
Vaccines |
|
2024
|
Invention
|
Immunoglobulin a protease polypeptides, polynucleotides, and uses thereof. This disclosure relate... |
|
|
Invention
|
Humanized anti-cd3 binding molecules and uses thereof. Described herein are humanized anti-CD3 an... |
|
|
Invention
|
Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria. in vivoi... |
|
|
Invention
|
Chemical stability of mrna. Some aspects of the disclosure relate to mRNAs in which a higher prop... |
|
|
Invention
|
Delivery and formulation of engineered nucleic acids.
Provided are formulations, compositions an... |
|
|
Invention
|
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof.
The present disclosure p... |
|
|
Invention
|
Human cytomegalovirus rna vaccines.
The disclosure describes HCMV ribonucleic acid (RNA) vaccine... |
|
|
Invention
|
C-met binding antibodies, nucleic acids encoding same, and methods of use. Described herein are a... |
|
|
Invention
|
Nucleic acid vaccines.
The invention relates to compositions and methods for the preparation, ma... |
|
|
Invention
|
Respiratory syncytial virus vaccine.
The disclosure relates to respiratory syncytial vims (RSV) ... |
|
|
Invention
|
Varicella-zoster virus mrna vaccine. Provided herein are optimized messenger ribonucleic acid (mR... |
|
|
Invention
|
Vlp enteroviral vaccines. Aspects of the disclosure relate to compositions of messenger RNA vacci... |
|
|
Invention
|
Hiv rna vaccines.
Provided herein are methods and compositions for inducing in a subject a broad... |
|
|
Invention
|
Mers-cov mrna vaccines. Aspects of the present disclosure relate to mRNA vaccines encoding Middle... |
|
|
Invention
|
Betacoronavirus rna vaccines. The disclosure relates to ribonucleic acid (RNA) vaccines and combi... |
|
|
Invention
|
Combination hmpv/rsv rna vaccines.
The disclosure relates to ribonucleic acid (RNA) vaccines and... |
|
|
Invention
|
Modified polynucleotides for the production of biologics and proteins associated with human disea... |
|
|
Invention
|
Sars-cov-2 t cell vaccines. Some aspects of the disclosure relate to mRNA vaccines encoding chime... |
|
|
Invention
|
Compounds and compositions for delivery of therapeutic agents. The disclosure features novel lipi... |
|
|
Invention
|
Stabilized flavivirus vaccines. Provided herein are engineered flavivirus heterotetrameric protei... |
|
|
Invention
|
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of... |
|
|
Invention
|
Tropical disease vaccines.
The disclosure relates to tropical diseases such as viral mosquito bo... |
|
|
Invention
|
Modified polynucleotides for the production of oncology-related proteins and peptides.
The inven... |
|
|
Invention
|
Varicella zoster virus (vzv) vaccine.
Aspects of the disclosure relate to nucleic acid vaccines.... |
|
2023
|
Invention
|
Modified polynucleotides for the production of secreted proteins.
The invention relates to compo... |
|
|
Invention
|
In vitro transcription dna purification and recycling.
Provided herein are methods of preparing ... |
|
2022
|
Invention
|
Processes for preparing lipid nanoparticles.
The present disclosure provides processes for contr... |
|
|
Invention
|
Determination of encapsulation efficiency of lipid nanoparticles.
Methods of assessing the perce... |
|
|
Invention
|
Compositions for the delivery of payload molecules to airway epithelium.
The present disclosure ... |
|
|
Invention
|
Methods of purifying dna for gene synthesis.
Provided herein are methods of purifying nucleic ac... |
|
|
Invention
|
Custom bacterial strain for recombinant protein production.
Described here are genetically modif... |
|
|
Invention
|
Markerless dna production.
Provided herein are genetically modified microorganisms comprising a ... |
|
|
Invention
|
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease.
Th... |
|
|
Invention
|
Multicolumn chromatography mrna purification.
Described herein are methods of purifying nucleic ... |
|
|
Invention
|
Mrnas encoding chimeric metabolic reprogramming polypeptides and uses thereof.
The disclosure fe... |
|
|
Invention
|
Extraction-less reverse phase (rp) chromatography of mrna encapsulated in lipid nanoparticles for... |
|
|
Invention
|
Polynucleotides encoding glucose-6-phosphatase for the treatment of glycogen storage disease type... |
|
|
Invention
|
Processes for preparing lipid nanoparticle compositions for the delivery of payload molecules to ... |
|
|
Invention
|
Pan-human coronavirus vaccines.
The disclosure relates to pan human coronavirus ribonucleic acid... |
|
|
Invention
|
Pan-human coronavirus domain vaccines.
The disclosure relates to pan human coronavirus ribonucle... |
|
|
Invention
|
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the... |
|
|
Invention
|
Engineered polynucleotides for cell-type or microenvironment-specific expression.
The disclosure... |
|
|
Invention
|
Synthesis of trinucleotide and tetranucleotide caps for mrna production.
Provided herein are met... |
